#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians need to recognize that cannabis use in older adults may contribute to mental health deterioration, requiring routine screening during geriatric assessments and careful medication review given polypharmacy risks in this population. Patients considering cannabis for pain or other age-related conditions should discuss mental health risks with their providers, as depression and anxiety are both common in aging and potentially worsened by cannabis use. This evidence supports the importance of comprehensive, rather than siloed, clinical evaluation when older adults introduce cannabis into their treatment regimens.
A recent study examining trends in cannabis use among older adults found associations between increased cannabis consumption and adverse mental health outcomes, including depression and anxiety symptoms. The research emphasizes that geriatricians and other clinicians should consider cannabis use within the broader context of aging and mental health rather than treating it as an isolated behavior. This finding is particularly relevant given the growing accessibility of cannabis products in states with legalization and the increasing proportion of older adults experimenting with cannabis for perceived medical benefits. Clinicians should screen older patients for cannabis use and mental health symptoms concurrently, recognizing that cannabis may exacerbate mood disorders rather than alleviate them. Additionally, these findings suggest that patient education about cannabis risks should be integrated into discussions about mental health management in aging populations. Clinicians should ask about cannabis use during mental health assessments and consider it a potential contributing factor when older patients report new or worsening depression or anxiety.
“The correlation we’re seeing between increased cannabis use and mental health decline in older populations deserves our clinical attention, but we need to distinguish between causation and confounding variables like underlying depression driving both the use and the poor outcomes. In my practice, I’ve found that patients who benefit most from cannabis are those with specific, measurable conditions where we establish baseline mental health status first and monitor carefully, rather than those self-medicating for generalized distress.”
🧠 As cannabis use increases among older adults, clinicians should remain attentive to potential mental health impacts, though the relationship between cannabis and psychiatric outcomes is bidirectional and incompletely understood. The evidence linking cannabis to depression, anxiety, and cognitive changes is strongest for heavy, prolonged use and in individuals with genetic vulnerability to psychosis, yet many patients self-medicate with cannabis for these same conditions, making causality difficult to establish in clinical settings. Geriatricians and primary care providers should routinely ask older patients about cannabis use with the same care afforded to alcohol screening, particularly given age-related changes in drug metabolism and increased polypharmacy that may amplify psychiatric side effects. Clinicians should also consider that motivations for use often reflect inadequately treated pain or insomnia rather than recreational choice, and that abrupt cessation may worsen mood symptoms. A practical approach involves documenting baseline mental health status, monitoring for
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: